Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$0.45
NASDAQLPCN
Open
$0.43
Change
$0.01 (3.35%)
Day's Range
$0.43 - $0.46
52-Week Range
$0.36 - $1.89
Volume
91.9K
Market Cap
$39.8M